Company Filing History:
Years Active: 2011-2013
Title: Innovations by Jeffery Dove in Bioprosthetic Tissue Treatment
Introduction
Jeffery Dove is a notable inventor based in Santa Ana, CA (US), recognized for his contributions to the field of bioprosthetic tissue treatment. With a total of 2 patents, Dove has made significant strides in reducing calcification in bioprosthetic materials used in medical implants.
Latest Patents
Dove's latest patents focus on a method for capping bioprosthetic tissue to mitigate calcification. This innovative treatment is designed for bioprosthetic tissue used in implants or assembled bioprosthetic heart valves. The method involves applying a calcification mitigant, such as a capping agent or antioxidant, to the tissue to specifically inhibit oxidation. This approach not only helps in reducing in vivo calcification but also inhibits oxidation in dehydrated tissue. The capping agent plays a crucial role by suppressing the formation of binding sites in the tissue that could attract calcium, phosphate, immunogenic factors, or other precursors to calcification. In one method, tissue leaflets in assembled bioprosthetic heart valves are pretreated with an aldehyde capping agent prior to dehydration and sterilization.
Career Highlights
Jeffery Dove is currently associated with Edwards Lifesciences Corporation, a leading company in the medical technology sector. His work has been instrumental in advancing the field of bioprosthetic implants, contributing to improved patient outcomes.
Collaborations
Dove has collaborated with notable colleagues, including Darin P Dobler and Jim Davidson, to further enhance the innovations in bioprosthetic tissue treatments.
Conclusion
Jeffery Dove's innovative work in capping bioprosthetic tissue represents a significant advancement in medical technology. His contributions are paving the way for improved treatments in the field of bioprosthetics, ultimately benefiting patients worldwide.